Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY 4.0Frontiers in Neurology

Clinical facial weakness and multimodal electrophysiology in amyotrophic lateral sclerosis: motor unit number index, nerve conduction, and blink reflex

  1. 1Department of Neurology, Central Hospital, Tianjin University/Tianjin Third Central Hospital
  2. 2Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases
  3. 3Tianjin Artificial Cell Engineering Technology Research Center

Abstract

Background: Cheek-puff weakness is clinically recognised in amyotrophic lateral sclerosis (ALS), but its relation to non-invasive facial electrophysiology is uncertain.

Objective: The primary objective was to test whether participant-level orbicularis oris motor unit number index (MUNIX) was lower in ALS than in healthy controls after age and sex adjustment. Secondary and exploratory objectives related cheek-puff weakness to facial MUNIX, nerve conduction, blink reflex, and onset phenotype.

Methods: In this retrospective cross-sectional study, we analysed 43 patients with ALS, 25 healthy controls (Control A), and 42 peripheral vestibular disease controls (Control B).

Results: The adjusted primary MUNIX difference versus Control A was not significant ( β = −7.08; p = 0.153). Cheek-puff weakness was more frequent than eye-closure weakness (21/43 versus 4/43; exact McNemar p < 0.001) and was associated with lower orbicularis oris MUNIX after age and sex adjustment ( β = −13.09; p = 0.006). In limb-onset ALS, cheek-puff weakness remained associated with lower MUNIX after additional adjustment ( β = −17.40, 95% confidence interval −30.56 to −4.25; p = 0.011); only nine patients had bulbar-onset ALS, limiting comparison between onset groups. Orbicularis oris distal motor latency remained longer after adjustment ( p = 0.011), and R2 was abnormal in 11/39 patients versus 0/42 Control B participants ( p < 0.001).

Conclusion: Assessment of cheek puff and eye closure is relevant irrespective of ALS onset site. Orbicularis oris MUNIX was associated with clinically observed cheek-puff weakness but was not supported as a stand-alone ALS marker. Distal latency and R2 provided additional, largely non-overlapping information. Prospective validation against cranial-muscle electromyography and longitudinal bulbar outcomes is required.

Related

  1. GDF5 as a Multimodal Protector of the Motor Unit in Amyotrophic Lateral Sclerosis
    Aly Bourguiba, Sonia Pezet, Massiré Traoré +15
    HALPreprintCC BY-NC-ND 4.0Full textNeurologyHAL
  2. Multivariate analysis identifies distinct latent components and highlights the contribution of motor cortex neurochemistry to clinical variance in amyotrophic lateral sclerosis
    Aakanksha Singh, Tobias R. Baumeister, Nicolas Dupré +19
    Scientific ReportsPeer-reviewedCC BY 4.0Full textNeurologyCrossref
  3. Multimodal Effects of CD40L Blockade in Multiple Sclerosis: Insights from Preclinical and Clinical Studies
    Ismail Muwenda, Joshua S. Mytych, Ekdanai Uawithya +3
    Multiple sclerosis (Houndmills, Basingstoke, England)Peer-reviewedLicence not statedFull textGeneral medicinePMC
  4. Transcutaneous Carbon Dioxide Monitoring in Amyotrophic Lateral Sclerosis: A Scoping Review
    Cláudia Santos Silva, Mamede de Carvalho
    European journal of neurologyPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  5. The value of a family history to distinguish monogenic from polygenic amyotrophic lateral sclerosis
    P. Beele, J. Veldink, W. van Rheenen
    medRxivPreprintAll rights reservedFull textNeurologymedRxiv
BibTeX
@article{wang2026clinical,
  title = {{Clinical facial weakness and multimodal electrophysiology in amyotrophic lateral sclerosis: motor unit number index, nerve conduction, and blink reflex}},
  author = {Yu Wang and Yanping Ren and Ju Zhu and Na Liu and Li Tian},
  journal = {Frontiers in Neurology},
  year = {2026},
  month = nov,
  doi = {10.3389/fneur.2026.1982458},
  url = {https://www.frontiersin.org/articles/10.3389/fneur.2026.1982458/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Clinical facial weakness and multimodal electrophysiology in amyotrophic lateral sclerosis: motor unit number index, nerve conduction, and blink reflex
AU  - Yu Wang
AU  - Yanping Ren
AU  - Ju Zhu
AU  - Na Liu
AU  - Li Tian
PY  - 2026
DA  - 2026/11/16
JO  - Frontiers in Neurology
DO  - 10.3389/fneur.2026.1982458
UR  - https://www.frontiersin.org/articles/10.3389/fneur.2026.1982458/full
AB  - Background: Cheek-puff weakness is clinically recognised in amyotrophic lateral sclerosis (ALS), but its relation to non-invasive facial electrophysiology is uncertain.  Objective: The primary objective was to test whether participant-level orbicularis oris motor unit number index (MUNIX) was lower in ALS than in healthy controls after age and sex adjustment. Secondary and exploratory objectives related cheek-puff weakness to facial MUNIX, nerve conduction, blink reflex, and onset phenotype.  Methods: In this retrospective cross-sectional study, we analysed 43 patients with ALS, 25 healthy controls (Control A), and 42 peripheral vestibular disease controls (Control B).  Results: The adjusted primary MUNIX difference versus Control A was not significant ( β = −7.08; p = 0.153). Cheek-puff weakness was more frequent than eye-closure weakness (21/43 versus 4/43; exact McNemar p < 0.001) and was associated with lower orbicularis oris MUNIX after age and sex adjustment ( β = −13.09; p = 0.006). In limb-onset ALS, cheek-puff weakness remained associated with lower MUNIX after additional adjustment ( β = −17.40, 95% confidence interval −30.56 to −4.25; p = 0.011); only nine patients had bulbar-onset ALS, limiting comparison between onset groups. Orbicularis oris distal motor latency remained longer after adjustment ( p = 0.011), and R2 was abnormal in 11/39 patients versus 0/42 Control B participants ( p < 0.001).  Conclusion: Assessment of cheek puff and eye closure is relevant irrespective of ALS onset site. Orbicularis oris MUNIX was associated with clinically observed cheek-puff weakness but was not supported as a stand-alone ALS marker. Distal latency and R2 provided additional, largely non-overlapping information. Prospective validation against cranial-muscle electromyography and longitudinal bulbar outcomes is required.
SN  - 1664-2295
ER  -